TuisSDGR • NASDAQ
add
Schrodinger Inc
Vorige sluiting
$20,37
Dagwisseling
$20,08 - $21,21
Jaarwisseling
$16,67 - $38,00
Markkapitalisasie
1,52 mjd USD
Gemiddelde volume
806,26 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 35,29 m | -17,10% |
Bedryfskoste | 86,15 m | 7,91% |
Netto inkomste | -38,14 m | 38,51% |
Netto winsgrens | -108,06 | 25,83% |
Wins per aandeel | -0,87 | -24,29% |
EBITDA | -66,86 m | -21,75% |
Effektiewe belastingkoers | 0,24% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 388,68 m | -21,68% |
Totale bates | 669,30 m | -15,72% |
Totale aanspreeklikheid | 219,87 m | -4,64% |
Totale ekwiteit | 449,42 m | — |
Uitstaande aandele | 72,86 m | — |
Prys om te bespreek | 3,30 | — |
Opbrengs op bates | -25,20% | — |
Opbrengs op kapitaal | -29,30% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | -38,14 m | 38,51% |
Kontant van bedrywe | -33,26 m | 33,41% |
Kontant van beleggings | 90,70 m | 587,00% |
Kontant van finansiering | 392,00 k | -70,53% |
Netto kontantverandering | 57,84 m | 263,35% |
Beskikbare kontantvloei | -14,71 m | 61,72% |
Meer oor
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
HUB
Gestig
1990
Webwerf
Werknemers
867